Researchers discover a new neural biomarker for obsessive-compulsive disorder (OCD), a specific neural activity pattern to accurately predict and monitor people with OCD who have undergone deep brain stimulation (DBS). OCD is a common and debilitating condition that affects 2-3% people worldwide.

Read Full Article

#OCD #NeuralBiomarker #DeepBrainStimulation #ResearchDiscovery #BrainHealth

People with obsessive-compulsive disorder (OCD) may benefit from psychedelic-assisted therapy. Psychedelic-assisted therapy followed by exposure and response (or ritual) prevention (ERP) may be more effective long-term for people with OCD.

Read Full Article

#OCD #PsychedelicTherapy #ERP #MentalHealth #TreatmentOptions

Gut bacteria are associated with obsessive-compulsive disorder (OCD) 🦠. Mendelian randomization shows these bacteria are causal 🔬. That makes dietary interventions plausible as a treatment for OCD 🍽️.

Read Full Article

#GutHealth #OCD #MendelianRandomization #DietaryInterventions #MentalHealthAwareness

Hoarding Disorder 🏠📦 is a type of obsessive-compulsive condition characterized by difficulty discarding objects leading to clutter compromising living spaces. 6% of older adults have hoarding disorder, compared to 2% of population. Hoarders say they feel stigmatized and face 'everyday discrimination'.

Read Full Article

#HoardingDisorder #MentalHealthAwareness #OCD #SupportHoarders #EndStigma

Potential bridge between narcissism and OCD: the drive for perfection may be the bridge connecting narcissism to obsessive-compulsive symptoms. For people with narcissistic traits, the inability to meet their own lofty standards is a primary driver of intrusive thoughts and compulsive behaviors. 🧠✨🔗

Read Full Article

#Narcissism #OCD #Perfectionism #MentalHealth #Psychology

🍄 New clinical trial suggests multiple doses of psilocybin, the active compound in "magic mushrooms," may offer significant relief for obsessive-compulsive disorder (OCD). The study, published in the Journal of Psychopharmacology, found that weekly treatments were safe and effectively reduced obsessive thoughts and compulsive behaviors.

🔬 The research involved 15 adults with moderate to severe OCD who had not responded to standard therapies. After an eight-week program involving weekly high doses of psilocybin, approximately 73% of participants showed at least a 35% reduction in symptom severity, with 40% experiencing complete symptom remission.

🧠 Psilocybin works by affecting serotonin receptors in the brain, increasing cognitive flexibility and altering neural networks associated with habitual responding. This is particularly relevant for OCD, which is characterized by rigid thought patterns and repetitive behaviors.

6️⃣ Follow-up six months later indicated that symptom reductions remained substantial for a large portion of participants, suggesting potential for lasting benefit. Researchers are planning larger-scale studies to further investigate psilocybin's efficacy and optimal dosing for OCD.

#Psilocybin #OCD #MentalHealth

Researchers found that serotonin helps reduce "belief stickiness" — the tendency to get stuck on an old idea despite new contradicting evidence. This discovery holds important implications for the understanding and treatment of obsessive-compulsive disorder (OCD)

Read Full Article

#Serotonin #OCD #CognitiveFlexibility

🧠 Researchers at Brown University discovered serotonin reduces "belief stickiness," helping people adapt to new information and let go of old ideas, even when faced with contradictory evidence.

💊 This breakthrough offers new insights into understanding and treating Obsessive-Compulsive Disorder (OCD), potentially changing therapeutic approaches.

🧪 An experiment involving 50 volunteers showed that a medication increasing serotonin (escitalopram) significantly reduced belief stickiness compared to a placebo, improving participants' ability to adapt to changing game conditions.

💡 The findings suggest that SSRIs may help OCD by enabling individuals to update their understanding of environmental changes, explaining their therapeutic effectiveness.

#Neuroscience #OCD #MentalHealth

💊 Three adults in Hong Kong (May-Nov 2025) with severe bipolar disorder and OCD symptoms showed improvement using an oral ketamine-mimetic protocol ("Cheung Glutamatergic Regimen").

💊 The regimen includes dextromethorphan, fluoxetine, piracetam, and L-glutamine. It aims to modulate NMDA and AMPA receptors.

💊 Sustained symptom relief was observed after adding piracetam, with significant reductions in depressive, anxious, and compulsive behaviors. Scores on PHQ-9 and GAD-7 decreased markedly.

💊 This approach may offer an affordable and practical alternative for patients with this difficult-to-treat condition who haven't responded to standard treatments.

#BipolarDisorder #OCD #MentalHealth

Researchers have identified 36 genes that substantially raise the risk for obsessive-compulsive disorder (OCD) and chronic tic disorders – providing what two researchers said is the most detailed biological understanding of how these conditions develop – and how they might eventually be treated

Read Full Article

#OCD #ObsessiveCompulsiveDisorder #GeneticsResearchers

🧬 36 New Genetic Risk Factors Found for OCD and Tic Disorders
A Rutgers-led international team identified 36 genes substantially increasing risk for obsessive-compulsive disorder (OCD) and chronic tic disorders. This study, published in Nature Neuroscience, provides the most detailed biological understanding of these conditions and potential future treatments, expanding the catalog of shared risk genes and highlighting connections with autism and schizophrenia.

🧠 Shared Genes & Brain Circuitry
Many of the 36 newly identified genes are shared between OCD and chronic tic disorders, explaining why they often co-occur. The findings point to disruptions in the same brain pathways governing impulse control, movement, and habit formation, opening up possibilities for targeting entire gene networks for therapy development.

🔬 Advancing Treatment Possibilities
With over 30 potential gene targets identified, this research dramatically expands opportunities for the pharmaceutical industry to develop new drugs. Instead of just managing symptoms, future treatments can aim to target the underlying biological mechanisms influencing neurotransmitter signals in the brain.

#OCD #Tourettes #Genetics